ALPS Medical Breakthroughs ETF
SBIO
28 hedge funds and large institutions have $20.9M invested in ALPS Medical Breakthroughs ETF in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 11 reducing their positions, and 3 closing their positions.
107% more call options, than puts
Call options by funds: $592K | Put options by funds: $286K
100% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 3
30% more capital invested
Capital invested by funds: $16.1M → $20.9M (+$4.82M)
8% more funds holding
Funds holding: 26 → 28 (+2)
4.41% more ownership
Funds ownership: 15.43% → 19.84% (+4.4%)
45% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wells Fargo
San Francisco,
California
|
+$2.11M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$1.44M |
| 3 |
Credit Agricole
Montrouge Cedex,
France
|
+$1.08M |
| 4 |
LPL Financial
San Diego,
California
|
+$968K |
| 5 |
CT
Cambridge Trust
Cambridge,
Massachusetts
|
+$407K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.08M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$692K |
| 3 |
Jane Street
New York
|
-$542K |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$539K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$508K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GT
26
Glenmede Trust
Philadelphia,
Pennsylvania
| $5K | – | – | – |
|
27
Simplex Trading
Chicago,
Illinois
| $5K | +$5.08K | +204 | New |
|
|
AWM
28
AllSquare Wealth Management
Albany,
New York
| $2K | +$1.77K | +71 | New |
|
|
PFS
29
Prospera Financial Services
Dallas,
Texas
| – | -$443K | -18,275 | Closed |
|
|
VKH
30
Virtu KCG Holdings
New York
| – | -$328K | -14,295 | Closed |
|
31
Ameriprise
Minneapolis,
Minnesota
| – | -$226K | -9,868 | Closed |
|
SBIO Hedge Fund Activity: Q1 2017 in Review
28 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2017, worth a combined $20.9M — up 30% from $16.1M a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new SBIO positions and 3 closed out — a net gain of 3 holders — while 6 added to existing stakes and 11 trimmed.
The largest buyer was Wells Fargo, adding an estimated $2.11M. The largest seller was Susquehanna International Group, cutting an estimated $1.08M.
- 28 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2017, up from 26 in Q4 2016.
- Funds reported $20.9M of ALPS Medical Breakthroughs ETF stock for Q1 2017, up 30% quarter-over-quarter.
- 6 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2017 and 3 closed out, a net change of +3 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2017 was Wells Fargo, an estimated $2.11M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2017 was Susquehanna International Group, an estimated $1.08M sold.
Based on aggregated 13F filings for Q1 2017.